RSV antibody drug gets backing from FDA advisors, paving the way for approval : Shots - Health News
A panel of advisers to the Food and Drug Administration have recommended that the agency approve a new antibody drug to protect infants from serious lung illnesses caused by respiratory syncytial virus, also known as RSV. On Thursday, the panel voted in favor of FDA approval for the injectable…
#rsv #fda #astrazeneca #maryannejackson #childrenmercy #kansascity #missouri #stevenkrug #lindseybaden #boston